4.6 Review

The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Polygenic Risk Score for Defining Personalized Surveillance Intervals After Adenoma Detection and Removal at Colonoscopy

Feng Guo et al.

Summary: This study aimed to evaluate whether a polygenic risk score (PRS) could help define personalized and risk-adapted colorectal cancer (CRC) screening strategies. The study found significant variations in CRC risk based on the PRS, including among individuals with detection and removal of adenomas at colonoscopy. Considering genetic susceptibility, using the PRS to determine risk-adapted surveillance intervals may be helpful.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Oncology

Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer risk

Matteo Giaccherini et al.

Summary: This study analyzed the common genetic variability of PDAC familial genes and found that the CDKN2B-AS1/ANRIL gene located in the 9p21.3 region plays an important role in the development of PDAC. The results strongly support the association between genetic variability in the 9p21.3 region and PDAC pathogenesis.

INTERNATIONAL JOURNAL OF CANCER (2023)

Article Gastroenterology & Hepatology

Genetic and non-genetic risk factors for early-onset pancreatic cancer

Ylenia Nodari et al.

Summary: This study found that established risk factors for pancreatic cancer may not have a strong age-related effect on early-onset pancreatic cancer (EOPC) patients. Furthermore, smoking and diabetes play important roles in EOPC.

DIGESTIVE AND LIVER DISEASE (2023)

Article Oncology

Rare germline variants in pancreatic cancer and multiple primary cancers: an autopsy study

Hiroo Fujitani et al.

Summary: A retrospective study on autopsy cases in Japan found rare germline variants of pancreatic cancer-predisposing genes in individuals with no family history. The study also identified several genes associated with cancer predisposition and found significant associations between pancreatic cancer and DNA mismatch repair genes (MLH1, MSH2, MSH6, and PMS2) and POLQ in men.

EUROPEAN JOURNAL OF CANCER PREVENTION (2023)

Article Biochemistry & Molecular Biology

An 8q24 Gain in Pancreatic Juice Is a Candidate Biomarker for the Detection of Pancreatic Cancer

Iris J. M. Levink et al.

Summary: This study evaluates the feasibility and performance of shallow sequencing for detecting copy number variations in cell-free DNA from pancreatic juice for pancreatic cancer detection. The presence of an 8q24 gain in pancreatic juice shows promise as a biomarker for the detection of pancreatic cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Oncology

Polygenic risk scores and breast cancer risk prediction

Eleanor Roberts et al.

Summary: Polygenic Risk Scores (PRS) play a crucial role in accurate breast cancer risk prediction and have the potential to improve screening and prevention strategies. By combining the risk from single nucleotide polymorphisms (SNPs) associated with breast cancer in Genome Wide Association Studies (GWAS), PRS explain over 30% of the heritability of breast cancer. Incorporating PRS into risk models enables personalized risk assessment and the implementation of stratified screening and prevention approaches.

BREAST (2023)

Article Oncology

Genetic Ancestry Inference from Cancer-Derived Molecular Data across Genomic and Transcriptomic Platforms

Pascal Belleau et al.

Summary: The study explores the feasibility and accuracy of inferring genetic ancestry from cancer-derived data. A data synthesis framework is developed to optimize and evaluate the performance of ancestry inference based on various molecular profiles. The results demonstrate the accuracy and robustness of the inference procedure, making it possible to determine the continental-level ancestry of cancer patients.

CANCER RESEARCH (2023)

Review Oncology

Germline genetic variability in pancreatic cancer risk and prognosis

Manuel Gentiluomo et al.

Summary: Pancreatic cancer is a rare but highly lethal disease. Research on genetic factors, including common loci and rare variants, is important for understanding the risk of pancreatic cancer.

SEMINARS IN CANCER BIOLOGY (2022)

Review Oncology

Prognostic role of cell-free DNA biomarkers in pancreatic adenocarcinoma: A systematic review and meta-analysis

Stefania Bunduc et al.

Summary: This systematic review and meta-analysis found that detectable cell-free DNA (cfDNA) biomarkers are associated with accelerated progression and decreased survival in pancreatic ductal adenocarcinoma (PDAC). The presence of circulant-tumor DNA (ctDNA) and KRAS mutations in cfDNA is linked to poorer overall and progression-free survival across various stages of PDAC. In cases where surgery is not feasible, the detection of ctDNA indicates a higher risk of disease progression, while the significance of KRAS mutations detection needs further investigation.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2022)

Review Oncology

Evolving pancreatic cancer treatment: From diagnosis to healthcare management

Michele Milella et al.

Summary: This review addresses the main unanswered questions about the clinical management of pancreatic ductal adenocarcinoma, aiming to provide practical decision support for physicians.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2022)

Review Genetics & Heredity

Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review

Padraig Dixon et al.

Summary: This study assessed the cost-effectiveness of using polygenic risk scores for cancer screening and found that polygenic risk-informed screening may be more cost-effective. However, due to the lack of robust evidence, the practical application of polygenic risk stratification in cancer screening remains uncertain.

GENETICS IN MEDICINE (2022)

Article Endocrinology & Metabolism

Genetically Determined Telomere Length Is Associated with Pancreatic Neuroendocrine Neoplasms Onset

Manuel Gentiluomo et al.

Summary: This study generated a teloscore using 11 SNPs and found an association between genetically determined long telomeres and an increased risk of developing PanNEN. Two novel SNPs associated with PanNEN risk were also identified in this study.

NEUROENDOCRINOLOGY (2022)

Article Oncology

A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNs

Matteo Giaccherini et al.

Summary: In this study, a polymorphic variant in the PXK gene was found to be associated with an increased risk of progression of intraductal papillary mucinous neoplasms (IPMNs). This novel finding highlights the importance of germline genetics in IPMN research.

CARCINOGENESIS (2022)

Article Multidisciplinary Sciences

Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women

Giulia Peduzzi et al.

Summary: The study found that common polymorphisms in the estrogen and pregnenolone pathways were not identified to be associated with the risk of pancreatic ductal adenocarcinoma (PDAC). However, the association between NR5A2 gene variants and PDAC risk was validated.

SCIENTIFIC REPORTS (2022)

Article Genetics & Heredity

Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction

Alice Alessandra Galeotti et al.

Summary: A polygenic risk score was generated for pancreatic ductal adenocarcinoma (PDAC) risk prediction, showing a significant association with increased PDAC risk. This could potentially aid in constructing a tool for risk stratification in the population.

JOURNAL OF MEDICAL GENETICS (2021)

Article Genetics & Heredity

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

David Conti et al.

Summary: The study identified 86 new genetic risk variants associated with prostate cancer, bringing the total known risk variants to 269. The top genetic risk score decile showed different odds ratios for men of European, African, and East Asian ancestries, highlighting the role of germline variation and providing a potential approach for personalized risk prediction.

NATURE GENETICS (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk

Ye Lu et al.

Summary: In this study, a re-analysis of pancreatic cancer GWAS data identified six SNPs associated with pancreatic cancer risk under a recessive genetic model. The results suggest the importance of considering non-additive genetic models in GWAS analysis and provide potential candidates for further meta-analysis to improve polygenic risk scores for pancreatic cancer. Additional bioinformatic analysis revealed a possible relationship between specific SNPs and genes known to be involved in pancreatic biology.

FRONTIERS IN ONCOLOGY (2021)

Article Multidisciplinary Sciences

Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival

Manuel Gentiluomo et al.

Summary: The study aimed to replicate the associations of CD44-rs353630 and CHI3L2-rs684559 genetic markers with survival in PDAC patients, but found only the heterozygous carriers of CD44-rs353630 were associated with worse overall survival in stage I disease patients. This suggests that data obtained in small subgroups may not be replicable.

SCIENTIFIC REPORTS (2021)

Article Oncology

Genetic Polymorphisms Involved in Mitochondrial Metabolism and Pancreatic Cancer Risk

Giulia Peduzzi et al.

Summary: Mitochondrial metabolism has been linked to PDAC risk, with genetic variability potentially playing a role. However, this study did not find significant associations between mtSNPs or n-mtSNPs and PDAC risk. Gene-level analysis highlighted three genes (TERT, SUGCT, and SURF1) that showed some association with PDAC, but not at a statistically significant level.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)

Review Medicine, General & Internal

Pancreatic Cancer: A Review

Wungki Park et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a relatively uncommon cancer with increasing incidence each year, resulting in a high percentage of patients being diagnosed with advanced disease. Current cytotoxic therapies for PDAC are moderately effective, emphasizing the importance of multidisciplinary management, comprehensive germline testing, and integrated supportive care for all patients.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Gastroenterology & Hepatology

Association of genetic variants affecting microRNAs and pancreatic cancer risk

Y. Lu et al.

PANCREATOLOGY (2021)

Review Genetics & Heredity

Genetic Risk Factors in Early-Onset Nonalcoholic Chronic Pancreatitis: An Update

Katarzyna Wertheim-Tysarowska et al.

Summary: Chronic pancreatitis is a progressive and irreversible inflammatory disorder of the pancreas caused by various genetic and environmental factors. Genetic variants play a significant role in early-onset nonalcoholic CP patients, with new CP-related genes continuously emerging from genetic studies. Functional studies have categorized genetic alterations into subgroups related to CP-driving pathological pathways.

GENES (2021)

Article Oncology

Genome-wide association study identifies an early onset pancreatic cancer risk locus

Daniele Campa et al.

INTERNATIONAL JOURNAL OF CANCER (2020)

Review Genetics & Heredity

Polygenic risk scores: from research tools to clinical instruments

Cathryn M. Lewis et al.

GENOME MEDICINE (2020)

Article Oncology

Analysis of Heritability and Genetic Architecture of Pancreatic Cancer: A PanC4 Study

Fei Chen et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)

Article Oncology

A Phenome-Wide Mendelian Randomization Study of Pancreatic Cancer Using Summary Genetic Data

Ryan J. Langdon et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)

Article Genetics & Heredity

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

Nasim Mavaddat et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2019)

Article Oncology

Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study

Daniele Campa et al.

INTERNATIONAL JOURNAL OF CANCER (2019)

Article Multidisciplinary Sciences

Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer

Alison P. Klein et al.

NATURE COMMUNICATIONS (2018)

Review Genetics & Heredity

Telomere Maintenance Mechanisms in Cancer

Tiago Bordeira Gaspar et al.

GENES (2018)

Article Oncology

Genome-wide scan of the effect of common nsSNPs on colorectal cancer survival outcome

Evropi Theodoratou et al.

BRITISH JOURNAL OF CANCER (2018)

Article Oncology

Risk and protective factors for the occurrence of sporadic pancreatic endocrine neoplasms

Roberto Valente et al.

ENDOCRINE-RELATED CANCER (2017)

Article Oncology

The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study

Robert Carreras-Torres et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)

Article Oncology

The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study

Robert Carreras-Torres et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)

Article Multidisciplinary Sciences

SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival

Beatrice Mohelnikova-Duchonova et al.

SCIENTIFIC REPORTS (2017)

Article Oncology

Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium

Daniele Campa et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)

Article Oncology

TERT gene harbors multiple variants associated with pancreatic cancer susceptibility

Daniele Campa et al.

INTERNATIONAL JOURNAL OF CANCER (2015)

Article Biochemistry & Molecular Biology

Factors associated with oxidative stress and cancer risk in the Breast and Prostate Cancer Cohort Consortium

S. Blein et al.

FREE RADICAL RESEARCH (2014)

Article Biochemistry & Molecular Biology

Mendelian randomization: genetic anchors for causal inference in epidemiological studies

George Davey Smith et al.

HUMAN MOLECULAR GENETICS (2014)

Article Genetics & Heredity

Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer

Brian M. Wolpin et al.

NATURE GENETICS (2014)

Article Genetics & Heredity

Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data

Stephen Burgess et al.

GENETIC EPIDEMIOLOGY (2013)

Article Multidisciplinary Sciences

Somatic Mutations in Exocrine Pancreatic Tumors: Association with Patient Survival

P. Sivaramakrishna Rachakonda et al.

PLOS ONE (2013)

Article Multidisciplinary Sciences

Pancreatic Cancer Susceptibility Loci and Their Role in Survival

Cosmeri Rizzato et al.

PLOS ONE (2011)

Article Gastroenterology & Hepatology

Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection

Sara Raimondi et al.

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2010)